chadi nabhan MD, MBA, FACP
@chadinabhan
Heme/Onc; NHL/HL/CLL. Adj Professor U of SC; Host: the #HealthcareUnfiltered podcast. Author of "TOXIC EXPOSURE" & “THE CANCER JOURNEY.” 3rd book out in 2026.
It’s OFFICIAL. Sep 24, 2024 My second book “The Cancer Journey” launches on #WorldCancerResearchDay a very special day celebrating research & the PTs it has helped. Simplifying cancer through storytelling. Pick up your copy & share with PTs & staff. a.co/d/8Hg5Wur
If you want to listen to “LIVE” taping of #HealthcareUnfiltered EXPRESS, join me with @VincentRK as we discuss in 10 mins or less thoughts on Blenrep and the recent ODAC ruling - 4 pm CST
Thanks @chadinabhan for this opportunity. @MayoHemeOnc @MayoCancerCare @MayoClinic @ASCO @Noha_Soror @BCMCancerCenter @BCM_CancerEd @oncodaily @HemOncFellows @HemOncWomenDocs @HemOncToday @DrYukselUrun @yuan_ruiling @WadeSwenson
This week on #HUExpress, @JasmineKambojMD joins the show to give advise to starting Hem/Onc fellows this July. How to survive & thrive in fellowship? COMING SOON. wonderful insights for all fellows @Noha_Soror @HemOncFellows @TheFellowOnCall @IMG_Oncologists @VincentRK
This week on #HUExpress, @JasmineKambojMD joins the show to give advise to starting Hem/Onc fellows this July. How to survive & thrive in fellowship? COMING SOON. wonderful insights for all fellows @Noha_Soror @HemOncFellows @TheFellowOnCall @IMG_Oncologists @VincentRK
The entire video #HealthcareUnfiltered podcast with @PallawiTorkaMD of @MSKCancerCenter reviewing the most recent data on #lymphoma from #ASCO25 and #EHA25 is here. let us know any thoughts on the discussion we had, and share with colleagues.
🔥 Lymphoma updates from the summer congresses. In this rapid fire conversation with @chadinabhan, I explore the highest yield data: what’s ready for prime time and hot topics to lookout for. Do give a listen 🙏🏻. @MSKCancerCenter @MSK_DeptOfMed @HemOncFellows @OncBrothers
Advances in Lymphoma: Report from ASCO and EHA 2025 youtu.be/cBIEnUZF97g?si… via @YouTube Watch my #HealthcareUnfiltered conversation with @PallawiTorkaMD of @MSKCancerCenter out now. Join the conversation on what’s new in lymphoma from #ASCO25 and #EHA25
Advances in Lymphoma: Report from ASCO and EHA 2025 youtu.be/cBIEnUZF97g?si… via @YouTube Watch my #HealthcareUnfiltered conversation with @PallawiTorkaMD of @MSKCancerCenter out now. Join the conversation on what’s new in lymphoma from #ASCO25 and #EHA25
What’s new in the lymphoma world? @PallawiTorkaMD discusses with me on #HealthcareUnfiltered today. Tune in and check it out - from bispecifics to CARTs and ADCs - all here. Pls subscribe, rate, and share podcasts.apple.com/us/podcast/hea…
Newest #HealthcareUnfiltered is out - @PallawiTorkaMD of @MSKCancerCenter reviewing recent potentially practice-changing data in lymphoma from #ASCO25 & #EHA25 - clip below & link to full pod here: podcasts.apple.com/us/podcast/hea… Check it out & join the conversation.
Tomorrow on #HealthcareUnfiltered, I’m joined by @PallawiTorkaMD of @MSKCancerCenter to give us lymphoma updates from #ASCO25 @ASCO and #EHA25 What’s new that may have clinical implications? Here’s a clip ahead of full podcast tomorrow morning.
✍️ Writing is thinking. 👉🏼A powerful editorial in Nature Reviews Bioengineering (Vol. 3, p. 431, 2025) reminds us of something timeless: in science, writing is far more than reporting results. It’s a way of sharpening thought. 👉🏼Even in an age shaped by large-language models,…
In this #HealthcareUnfiltered Express #HUExpress, @Dr_AmerZeidan of @SmilowCancer @Yale joins me to discuss the recent VERONA trial in high-risk MDS and the negative results publicized. what is next for HR-MDS? @Ramikomrokji @MikkaelSekeres @DavidSteensma @sanamloghavi
A #HealthcareUnfiltered EXPRESS #HUExpress with @Dr_AmerZeidan of @Yale @SmilowCancer is out soon to discuss the recent negative #VERONA trial in high-risk MDS. Join the conversation @DavidSteensma @Ramikomrokji @sanamloghavi @MikkaelSekeres @jaltmanmd @aditishasMD
Was very grateful to @chadinabhan for sharing his platform with me I’m a patient-physician but always live on the front part of that hyphenate and can’t avoid seeing new oncology data through the lens of embodied experience #asco25 cc: @ErikaHamilton9 @ASCO @ConquerCancerFd
THE @marklewismd spent 11 quick minutes on #HUExpress #HealthcareUnfiltered Express sharing the patient/doctor perspective on this past @ASCO #ASCO25 meeting. How can we assure patients' engagement and how to make the data interpretable & digestible. Join the conversation.
THE @marklewismd spent 11 quick minutes on #HUExpress #HealthcareUnfiltered Express sharing the patient/doctor perspective on this past @ASCO #ASCO25 meeting. How can we assure patients' engagement and how to make the data interpretable & digestible. Join the conversation.
The formidable @marklewismd joins #HUExpress this week sharing his reflections on the recent @ASCO #ASCO25 data from a “patient perspective.” Mark wears the patient hat here as he analyzes the data just as he did on the podium this past June. Full video shortly.
you can watch the entire #HealthcareUnfiltered with @bdermanmd of @UChicago @UChicagoMed right here. We talk everything myeloma and what was presented at @ASCO #ASCO25 as well as #EHA25 - watch, comment, and join the conversation.
Advances in Multiple Myeloma: Report from ASCO and EHA 2025 youtu.be/SnG7-ZId6MY?si… via @YouTube My #HealthcareUnfiltered with @bdermanmd is on my channel - watch the video and join the conversation. I will post the video ehre as well.
Imagine you're covering neurosurgery call. You're out trying to enjoy a nice family dinner, or maybe it's the middle of the night. Suddenly, you're called away for an acute traumatic subdural hematoma. You get there, the patient is herniating. You rush to the OR and…
Tune in to hear about MRD-directed decision making, CAR T updates, and TRIspecific antibodies!
What are the newest advances in myeloma? @bdermanmd joins my #HealthcareUnfiltered podcast to share latest date from #ASCO25 & #EHA25. Here’s a link to the full episode: podcasts.apple.com/us/podcast/hea… Take a listen & join the conversation.